physostigmine
See how the hazards of physostigmine combine into label elements for your jurisdiction (EU CLP, GB CLP, OSHA HazCom) — the correct pictograms, signal word and H-statements, with CLP Article 26 precedence applied and explained.
Handling and Storage Guidance for physostigmine
physostigmine has acute toxicity (oral, dermal, or inhalation) classified as Category 1–3. Access to this substance must be restricted to trained personnel. Store in a locked, well-ventilated area. Exposure monitoring and medical surveillance may be required under OSHA 29 CFR 1910.1000 or equivalent regulations.
This substance carries the signal word DANGER, indicating the more severe hazard categories under GHS/CLP. Facilities handling physostigmine should ensure a written hazard communication programme, including current SDS, employee training records, and GHS-compliant labelling on all containers.
This information is provided for reference only. Always consult the official Safety Data Sheet (SDS) and applicable national regulations before handling this substance.
The GHS classification shown above for physostigmine corresponds to Section 2 of its Safety Data Sheet. Learn how a compliant 16-section SDS is structured and authored.